A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis

BACKGROUND: Opioids are the most important pharmacological treatment for moderate-to-severe cancer pain, but side effects limit their use. Transdermal fentanyl (TDF) and oral prolonged-release oxycodone-naloxone (OXN-PR) are effective in controlling chronic pain, with less constipation compared to o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Pain Res
Hoofdauteurs: Roberto, A, Greco, MT, Legramandi, L, Galli, F, Galli, M, Corli, O
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590764/
https://ncbi.nlm.nih.gov/pubmed/28919810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S141928
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items